ContraFect (CFRX) to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Some multidrug-resistant gram-negative infections are resistant to nearly all antibiotics, and the remaining few treatment options can cause serious complications.